Market News & Trends
Regeneron & Avalanche to Develop Next-Generation Gene Therapy Products
Regeneron Pharmaceuticals, Inc. and Avalanche Biotechnologies, Inc. recently announced the formation of a broad collaboration to discover, develop, and commercialize novel gene therapy products for…
Indonesian Pharmaceutical Market Sees Rapid Expansion
Driven by increased government healthcare spending and growing life expectancy, the Indonesian pharmaceutical market value will climb from approximately $5 billion in 2013 to $9.9…
Growth Foreseen at All Levels of the Oral Solid Dosage Form Excipients Market
On a global scale, the oral solid dosage form (OSDF) excipients market is growing sustainably, historically exhibiting a robust increase. This market is valued at…
Novozymes A/S to Build $36-Million Facility, Create 100 R&D Jobs in the US
Novozymes recently announced the establishment of a new R&D center in the US dedicated to its bioagriculture business. The center will be located near the…
Capsugel Enters Agreement With Chiasma
Capsugel recently announced an agreement with Chiasma, Inc., wherein Capsugel’s Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only investigational oral…
Hollow Microstructured Transdermal System Available for Use in Preclinical Studies
3M Drug Delivery Systems Division recently announced the availability of the 3M hollow microstructured transdermal system (hMTS) for pharmaceutical and biotech companies interested in conducting…
Molecular Inhibitor Represents New Treatment Target for Drugs to Halt Atherosclerosis
Working with mice and rabbits, Johns Hopkins scientists have found a way to block abnormal cholesterol production, transport, and breakdown, successfully preventing the development of…
SMARTT e-Patch: A New Electronic Transdermal Patch
Rhenovia Pharma recently announced that its SMARTT e-Patch project has won an award at the World Innovation Challenge founded by the President of France to…
Novozymes' Half-Life Extension Technology Reaches Landmark Milestone Approval
The US FDA has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses…
Emerging Technologies Redefine Infectious Disease Diagnostics
The diagnostics market for infectious diseases, such as tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis C virus, and human papilloma virus is expanding, giving rise…
Big Pharma Seeking to Reduce Risk, Boost Profits Through Strategic Deals
High-priced pharmacy deals are all the rage this year as big drug companies stung by patent expirations attempt to offset losses and reduce risk and…
Are Mega M&As Back in Pharma?
According to Frost & Sullivan, the pharmaceutical industry is witnessing a new wave of mergers and acquisitions activities, especially mega M&As. Big pharma companies have…
Enterprise Content Management; Answer to Clinical Data Boom
The introduction of mandates involving meaningful use of data and various governmental eHealth initiatives across the globe are fuelling the adoption of electronic medical records…
UPM Signs Long-Term Agreement With Amerigen
UPM, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with Amerigen Pharmaceuticals, Inc. to commercially manufacture two ANDA products for a 10-year…
Link Technologies Announces New Modifier for Improved Oligo Delivery
Link Technologies Ltd. recently announced it has expanded its range of lipophilic modifiers for the effective delivery of oligonucleotides into cells. As oligos continue to…
Prosonix & Mylan Enter Global Licensing Agreement
Prosonix recently announced it has entered into a global licensing agreement with Mylan Inc. for its leading inhaled respiratory products, PSX1001 and PSX1050. PSX1001 and…
Oval Medical Receives Funding to Progress Container for Autoinjector Techgnology
Oval Medical Technologies Limited recently announced it has received a Smart funding award from the UK’s innovation agency, the Technology Strategy Board, of £228,256 for…
Mucosis Announces Strategic Partnership With Changchun BCHT Biotechnology
Mucosis B.V. recently announced it entered into a long-term collaboration and license agreement with China-based Changchun BCHT Biotechnology Co (BCHT) and raised EUR 5 million,…
Wearable Injectors: A Small Device That Can Make a Big Difference for IV Infusion
By: Alan Shortall, Chairman and CEO of Unilife. As part of a campaign to draw attention to the rising costs of healthcare in the U.S.,…
Mystic Pharmaceuticals Receives Patent for Packaging & Delivery Technology
Mystic Pharmaceuticals, Inc., recently announced it has been granted US Patent No. 8,683,995 Dose Dispensing Containers for its latest innovations in pharmaceutical packaging and dispensers.…
